SEC CIK 1064641 · Series S000006412 · Portfolio as of 2026-03-31
| Security | Value | Weight |
|---|---|---|
| Eli Lilly & Co · LLY | $5.30B | 13.70% |
| Johnson & Johnson · JNJ | $4.29B | 11.07% |
| AbbVie Inc · ABBV | $2.80B | 7.22% |
| Merck & Co Inc · MRK | $2.17B | 5.61% |
| UnitedHealth Group Inc · UNH | $1.78B | 4.61% |
| Amgen Inc · AMGN | $1.38B | 3.56% |
| Thermo Fisher Scientific Inc · TMO | $1.34B | 3.47% |
| Abbott Laboratories · ABT | $1.30B | 3.35% |
| Gilead Sciences Inc · GILD | $1.26B | 3.25% |
| Intuitive Surgical Inc · ISRG | $1.19B | 3.08% |
From N-PORT Part B, units verified by net-asset reconciliation.
curl "https://api.fundlens.io/v1/funds/XLV/holdings" \
-H "x-api-key: your_api_key"Full holdings, every historical snapshot, point-in-time queries, monthly returns and flows — free tier available, no card required.
Source: SEC EDGAR Form N-PORT. Data is quarterly with a regulatory filing lag; this page shows the most recent public filing. Not investment advice.